Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Hannah PleasantsDepartment of Epidemiology, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
Yaqun YuanDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan, USA.
Keran ChamberlinDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0003-4721-4316
Chenxi LiDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan, USA.
David CouperDepartment of Biostatistics, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.ORCID 0000-0002-4313-9235
Srishti ShresthaThe MIND Center, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Vidyulata KamathDepartment of Psychiatry and Behavioral Sciences, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-7711-3597
Jennifer A DealDepartment of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-6985-048X
Thomas H MosleyThe MIND Center, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Priya PaltaDepartment of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Jayant M PintoDepartment of Surgery, University of Chicago, Chicago, Illinois, USA.
Honglei ChenDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan, USA.
Anna Kucharska-NewtonDepartment of Epidemiology, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.ORCID 0000-0001-9864-467X
Funding
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028U01HL096812 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, THOMAS H MOSLEY · 2010 to 2026
$65.7M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.375N92022D00001 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID · 2022 to 2025
$13.7M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA L. · 2022 to 2025
$5.1M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WAGENKNECHT, LYNNE E · 2022 to 2025
$5.0M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00004 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI WINDHAM, BEVERLY GWEN · 2022 to 2025
$4.8M
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00002 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CORESH, JOSEF · 2022 to 2025
$4.7M
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's DiseaseR01AG064093 · NIA · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI BAKKER, ARNOLD, HUA, JUN · 2020 to 2024
$3.9M
Imaging small blood and lymphatic vessel abnormalities of the olfactory system in schizophreniaR01NS108452 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI HUA, JUN, KAMATH, VIDYULATA · 2018 to 2022
$3.2M
Poor sense of smell and the health of older adultsR01AG071517 · NIA · MICHIGAN STATE UNIVERSITY · PI HONGLEI CHEN · 2022 to 2026
backgroundEmerging evidence suggests that olfactory dysfunction may be a marker of frailty, a key predictor of adverse health outcomes in aging populations. This study examines the association between olfactory impairment and frailty in older adults.
methodsWe analyzed data from 5,231 participants (mean age: 75.3 ± 5.0 years; 59% women; 22% Black) of the Atherosclerosis Risk in Communities (ARIC) Study. Olfactory function, assessed using the 12-item Sniffin' Sticks Test at Visit 5 (2011-2013), was categorized as poor (0-8), moderate (9-10), or good (11-12). Frailty status was ascertained using both the Fried Frailty Phenotype and the Cumulative Frailty Index. Cross-sectional associations between olfactory function and frailty status were examined using logistic regression and linear regression. Logistic regression was used to examine the association between olfactory function and prefrailty or frailty occurring within five years among 1,519 participants robust at baseline.
resultsIn cross-sectional analyses, good olfactory function was associated with lower odds of frailty (odds ratio [OR] = 0.29, 95% confidence interval [CI]: 0.22, 0.39) and prefrailty (OR = 0.52, 95% CI: 0.45, 0.61). These associations remained robust after adjusting for covariates. Longitudinal analyses similarly showed a dose-response pattern, with improved olfaction associated with decreased odds of experiencing prefrailty (OR=0.63 95% CI [0.48, 0.83]) or frailty (OR=0.50, 95% CI [0.25, 1.02]).
conclusionsGood, as compared to poor, olfactory function is associated with lower frailty risk in older adults, suggesting that olfactory impairment may serve as an early marker of frailty. Further research is needed to elucidate the mechanisms linking olfaction and frailty and explore potential interventions.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Longitudinal Association of Olfactory Function with Frailty in Older Adults: The Atherosclerosis Risk in Communities Study. · full record | OpenQuestion